ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

Semax

Semax

Also known as: SEMAX, Heptapeptide Semax, MEHFPGP

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Semax

Increases BDNF and trkB receptor expression in the hippocampus and cortex. Modulates dopaminergic, serotonergic, and noradrenergic neurotransmission.

Dosing Information

Half-Life

~3-5 minutes (active metabolites persist longer)

Typical Dose

200–600 mcg

Frequency

1-3 times daily

Cycle Length

10-30 days (per Russian clinical protocols)

Administration Routes:
subcutaneous

Benefits

  • Significant upregulation of BDNF and NGF expression
  • Enhanced attention, memory formation, and learning capacity
  • Neuroprotective effects against oxidative stress and ischemia
  • Reduced anxiety without sedation
  • Improved cognitive performance under stress
  • Potential stroke recovery support

Side Effects

Mild nasal irritation with intranasal usemild
Occasional headachemild
Hair loss reported anecdotally at high dosesmild
Possible emotional blunting at very high dosesmild

Mechanism of Action

1

Increases BDNF and trkB receptor expression in the hippocampus and cortex

2

Modulates dopaminergic, serotonergic, and noradrenergic neurotransmission

3

Inhibits enkephalinase activity, prolonging endogenous enkephalin signaling

4

Melanocortin receptor (MC3/MC4) activation contributes to neuroprotective and anti-inflammatory effects

Contraindications

Do not use this peptide if any of the following apply:

  • Active seizure disorders (may lower seizure threshold in susceptible individuals)
  • Pregnancy or breastfeeding
  • Known hypersensitivity to ACTH-derived peptides

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

Semax has been approved in Russia and several CIS countries since 1994 for conditions including stroke recovery, cognitive impairment, and optic nerve atrophy. Russian clinical trials demonstrated improved cognitive scores in post-stroke patients and enhanced memory in healthy volunteers. Research shows robust BDNF upregulation (2-4 fold increases in hippocampal tissue) and significant neuroprotection in ischemia models. It is one of the most well-studied nootropic peptides globally, though it lacks Western regulatory trials.

Frequently Asked Questions

Common questions about Semax

UK-Specific Information

Exclusive data points and guidance for UK residents using Semax

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok